Tag: biosimilar vs generic
FDA Listing for Biosimilars: How They Are Evaluated and Approved
The FDA doesn't rate biosimilars like grades-it rigorously evaluates them for similarity to reference biologics. Learn how biosimilars are approved, why they're not generics, and what the Purple Book reveals about approved products and interchangeability.
Adverse Event Monitoring for Biosimilars: How Safety Surveillance Works in Real-World Use
Biosimilars require advanced safety monitoring due to their complex nature. Learn how adverse event tracking works, why product identification matters, and what systems are in place to ensure patient safety after approval.